Dental composites are getting simpler, but does that make things more confusing? In episode 30 of the Bonding and Beer Dental Podcast, Dr. Rolando goes in depth on what he believes to be the top 3 trends in composite dentistry today: Universal composites, Simplified shades, and composite warming. Visit our website! It's the perfect place to submit questions, suggestions, and learn more about the show: https://info.bisco.com/bonding-and-beer-landing Follow us on Instagram to stay updated wit...

Send us a text Växtskyddspodden E79 – Vad gör olika aktörer inom svenskt jordbruk för biodiversitet och biologisk mångfald? Hur kan lantbrukare, rådgivare och mat producenter arbeta för att öka biodiversiteten? Under Borgeby 2025 tog Robert Racz möjligheten att prata om just biodiversitet och biologisk mångfald med några av besökarna. Lantbrukarna Martin Andersson från Löderups Växt AB och Martin Krokstorp från Krokstorp Gård, Växtodlingsrådgivaren Mattias Hammarsted från HI...

Estamos de volta com um novo episódio do Podcast Molecular – Nos Bastidores da Ciência !Esta semana damos-te a conhecer novas oportunidades que se escondem no mercado de trabalho atual, através do inspirador testemunho de Pedro Simões. Mestre em Química Avançada, o Pedro seguiu um percurso pouco convencional na área da Propriedade Intelectual, construindo uma carreira sólida na indústria farmacêutica. Neste episódio vais poder alargar horizontes e descobrir a vasta gama de possibilidades que o mundo

30. FfE-ENERGIETAGE 2025 (Sponsoring): Vom 13. bis 15. Mai 2025 findet der zentrale Branchentreff der Energiewirtschaft in der Residenz in München statt. Das Thema lautet: „Resiliente Transformation bei globalen Turbulenzen“. Führende Expert:innen aus Energiewirtschaft, Wissenschaft und Gesellschaft kommen zusammen, um aktuelle Fragestellungen rund um die Transformation des Energiesystems zu diskutieren – wissenschaftlich fundiert und praxistauglich. Die Energietage bieten Raum für Austausch,

In this compelling episode of The Deep Dive, we explore the multifaceted story of pioglitazone, a thiazolidinedione (TZD) insulin sensitizer used to treat type 2 diabetes. From its origins in 1980s Japan to its development as a follow-up to troglitazone—the first but short-lived TZD—we trace how pioglitazone emerged as a promising therapy that targets insulin resistance at the genetic level through PPARγ activation. The episode explains its mechanism of action, pharmacokinetics, and clinical utility

In this episode of The Deep Dive, we explore the remarkable journey of exenatide, a diabetes medication that began in an unlikely place—Gila monster saliva. As the first GLP-1 receptor agonist approved for type 2 diabetes, exenatide paved the way for an entirely new class of blood sugar–lowering treatments. We trace its evolution from the twice-daily Byetta to the once-weekly Bydureon, highlighting the innovations in drug delivery—like microsphere formulations and prefilled pens—that made it more

In this expansive episode of The Deep Dive, we explore the full lifecycle of liraglutide, a first-generation GLP-1 receptor agonist that helped redefine how we treat both type 2 diabetes and obesity. From the early 20th-century discovery of incretin hormones to the molecular engineering breakthroughs that enabled liraglutide’s once-daily dosing, the episode traces the drug’s scientific and clinical journey in vivid detail. We break down its mechanism of action—including glucose-dependent insulin

Die Industrie und die Politik haben die große Chance erkannt, die die Natrium-Ionen-Technologie für Europa bietet. Die beiden internationalen Natrium-Experten Prof. Dominic Bresser und Prof. Philipp Adelhelm erläutern, wie weit wir mit der Technologie sind und welche Herausforderungen es noch gibt.

Meet the Scorpion King of Pest Control 👑🦂In this episode of Nisus Nation, Jason chats with Chaz Estrada—a passionate pest pro, spider enthusiast, and social media trailblazer. From AI and marketing to scorpion hunting and gaming communities, Chaz shares how the industry is evolving and why embracing change is key to its future. Don’t miss this wild and insightful ride!

האם הכל קשור לשיווק?שוחחנו עם הדס, סמנכל"ית שיווק GFI ישראל, להבין את תפקיד השיווק בתחום הפודטק, איך משתמשים בו בתעשייה משתנה וכיצד משווקים את התחום בישראל לעולם על רקע המציאות החדשה והאתגרים המתגלים.

In this comprehensive deep dive, we journey through the entire lifecycle of a medical device—from that first spark of an idea to post-market surveillance. The episode unpacks the structured and often invisible process that transforms innovation into real-world solutions. Starting with conceptualization and design input, the hosts guide listeners through risk management, design controls, verification and validation, and non-clinical testing under GLP. They break down complex concepts like the DHF,

Welcome to todays Galvanic talk! Interested in learning some Galvanic and fundamentals in electrochemical deposition? Then you're in the right place. This is for everybody interested in the why or studying for the next exam.

In this Deep Dive, we unravel the intricate story of Levofloxacin, a third-generation fluoroquinolone antibiotic with a sweeping medical profile and a regulatory history to match. Originally patented in 1987 and approved by the FDA in 1996, Levofloxacin quickly became a go-to option for serious bacterial infections like pneumonia, prostatitis, skin infections, and even life-threatening threats like anthrax and plague. The episode explores the drug’s mechanism of action—how it targets DNA gyrase and

Clindamycin may not be the flashiest antibiotic on the shelf, but its journey from a chlorinated cousin of lincomycin to a crucial treatment for bone infections, surgical prophylaxis, and penicillin-allergic patients tells a powerful story of medical utility and regulatory evolution. In this Deep Dive, we trace its origins back to 1970s FDA approvals and follow its regulatory path through updated labeling standards and quality assurance milestones, including how clear packaging and prescribing

In this sweeping exploration of Metformin, we uncover the remarkable transformation of a medieval herbal remedy into one of the world’s most essential medicines for managing type 2 diabetes. Originating from Galega officinalis—also known as goat’s rue—this botanical curiosity led scientists on a century-long quest, culminating in the rediscovery of Metformin after earlier biguanides proved too toxic. The episode traces its winding regulatory journey, including a decades-long delay before FDA

In this foundational episode, we explore how medical devices are defined and classified by the FDA—a critical first step in navigating the regulatory landscape. Starting with the legal distinction between devices and drugs, we unpack the FDA’s risk-based classification system that categorizes devices into Class I, II, or III based on their potential harm to patients. The discussion delves into how classification affects everything from pre-market submission pathways (like 510(k), De Novo, and PMA)

In this episode of Clinical Lab Chat, CLP Director of Business Intelligence Chris Wolski discusses the critical role diagnostics play in successful organ transplantation with Tina Liedtky, president of Transplant Diagnostics for Thermo Fisher.During the course of the lively conversation, they discuss: How diagnostics fit into the organ transplant process.How diagnostics are helping to up the odds of transplant success both short and long term.The role of post-transplantation diagnostics and

What do a love story, a sugar substitute, and genetically modified soybeans have in common? In this powerful episode, we trace the surprising origin and controversial legacy of Monsanto—from its founding by John Francis Queeny and his wealthy Puerto Rican wife, Olga Monsanto, to its transformation into a chemical and agricultural giant responsible for some of the most debated substances in modern history: saccharin, PCBs, DDT, Agent Orange, and Roundup-ready GMOs. We’ll explore the scientific...

While overdose deaths climb and homelessness surges, billions in taxpayer dollars disappear into broken systems and half-hearted solutions. And beneath it all, an industrial-sized drug economy thrives: unseen, unchallenged, and politically inconvenient.In this searing episode of The Opioid Matrix, Scott Silverman, CEO and Founder at Confidential Recovery, comes back to the show to dissect alongside Michael Brown the fentanyl-fueled collapse happening in plain sight.We dive into:How fentanyl has